The Impact of Epitranscriptomics on Antiviral Innate Immunity.
Détails
Télécharger: Mersinoglu, EpiTXP review, Viruses 2022.pdf (3942.81 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_169EFDDEF7AA
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
The Impact of Epitranscriptomics on Antiviral Innate Immunity.
Périodique
Viruses
ISSN
1999-4915 (Electronic)
ISSN-L
1999-4915
Statut éditorial
Publié
Date de publication
28/07/2022
Peer-reviewed
Oui
Volume
14
Numéro
8
Pages
1666
Langue
anglais
Notes
Publication types: Journal Article ; Review ; Research Support, Non-U.S. Gov't
Publication Status: epublish
Publication Status: epublish
Résumé
Epitranscriptomics, i.e., chemical modifications of RNA molecules, has proven to be a new layer of modulation and regulation of protein expression, asking for the revisiting of some aspects of cellular biology. At the virological level, epitranscriptomics can thus directly impact the viral life cycle itself, acting on viral or cellular proteins promoting replication, or impacting the innate antiviral response of the host cell, the latter being the focus of the present review.
Mots-clé
Antiviral Agents/pharmacology, DEAD Box Protein 58/metabolism, Immunity, Innate/genetics, Signal Transduction/genetics, Virus Replication/genetics, IFN-I response, RIG-I sensing, antiviral immunity, epitranscriptomics, viral infection
Pubmed
Web of science
Open Access
Oui
Financement(s)
Fonds national suisse / Projets / 314730_188877
Fondation Novartis / 21C149
Création de la notice
06/09/2022 10:37
Dernière modification de la notice
18/05/2023 6:08